Welcome - Home - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Search Results Your Search for 'obesity drug pipeline: developing therapies for a complex disease' returned 13 results - Page 1 of 1   Sort by    Report Name ASC Report Name DESC Report Price ASC Report Price DESC Rank ASC Rank DESC   Sorted by Rank Top-Bottom Competitor Analysis: Diabetes Drug Pipeline   La Merie, Nov 2008, Pages: 201 ... The pipeline of oral insulin shows at least seven ... Sales of Acomplia in 2007 for obesity just were ... A most recent analysis of emerging diabetes drugs and targets ... Impact of Pharmacogenomics on Public Healthcare Policy: Educating Patients, Payors and Healthcare Providers   Business Insights, March 2008, Pages: 171 ... tech research platform 62 Figure 3.19: Obesity patients stratified ... 3.30: Genzyme Genetics Product Pipeline 2008-2009 ... trials 37 Table 2.5: Drug withdrawals 1996 ... Outlook for RNAi, 2007: siRNA and miRNA in Biology, Diagnostics and Therapeutics   Business Insights, June 2007, Pages: 244 ... in the field, outlining their pipelines and describing the ... and validation Optimization of drug therapy and development ... disorders Diabetes and Obesity Key RNAi ... Gene Therapy - Technologies, Markets and Companies   Jain PharmaBiotech, Nov 2009, Pages: 659 ... mediated delivery of GDNF for obesity Gastrointestinal disorders ... 4: Bacteria plus nanoparticles for drug delivery into ... Table 13-3: Product pipeline of Medegene ... Nitric Oxide - Therapeutics, Markets and Companies   Jain PharmaBiotech, Nov 2009, Pages: 272 ... Role of NO in metabolic disorders Obesity Diabetes mellitus ... antioxidants Table 5-2: NO-related drugs Table 5-3 ... development Table 9-3: Product pipeline of Nitrox ... Emerging Biotechnology Players: From Innovation to Realization   Datamonitor, Jan 2003 ... Role of NO in metabolic disorders Obesity Diabetes mellitus ... antioxidants Table 5-2: NO-related drugs Table 5-3 ... development Table 9-3: Product pipeline of Nitrox ... Pipeline/Commercial Insight: Antihypertensives New class opportunity offset by key patent expiries   Datamonitor, July 2007, Pages: 261 ... mediated delivery of GDNF for obesity Gastrointestinal disorders ... 4: Bacteria plus nanoparticles for drug delivery into ... Table 13-3: Product pipeline of Medegene ... Stakeholder Opinions: Asthma Phenotypes A Changing Paradigm   Datamonitor, March 2007, Pages: 178 ... 02 Table 44: Celera Genomics' drug discovery and ... pipeline, 2001-02 Table 63: Obesity pipeline, 2001-02 ... 2004-07 Table 88: XOMA's pipeline revenue stream ... RNAi - Technologies, Markets and Companies   Jain PharmaBiotech, Nov 2009, Pages: 451 ... 24 Figure 5: The growing prevalence of obesity in the ... Figure 15: Wal-Marts $4 generic drug program web ... of factors 68 Figure 17: Pipeline antihypertensive agents ... Breast Cancer Therapeutics - Global Strategic Business Report   Global Industry Analysts, Inc., Oct 2006, Pages: 563 ... during childhood 66 Asthma and obesity 68 Chapter 5 ... study 3: an anti-inflammatory drug in neutrophilic ... Table 14: Marketed and pipeline therapies in eosinophilic ... Commercial Insight: Antihypertensives - New Challenges for a Maturing Market   Datamonitor, Sep 2006, Pages: 206 ... and metabolic disorders RNAi and obesity Genes and ... 3: Biotechnology companies using RNAi for drug discovery and ... ImuThes Table 10-8: Product pipeline of Silence ... Top 10 Medical Device Technology   MarketsandMarkets.com, Sep 2009, Pages: 210 ... and metabolic disorders RNAi and obesity Genes and ... 3: Biotechnology companies using RNAi for drug discovery and ... ImuThes Table 10-8: Product pipeline of Silence ... Minimal Invasive and Non Invasive Product and Service Market (2009 - 2014)   MarketsandMarkets.com, July 2009, Pages: 179 ... 26 Fat Intake II-26 Weight or Obesity II-26 ... Research and Development II-79 Product Development Timeline and Clinical Stages II-79 Pipeline Drugs (Phases I ... No more results

		Top of page

All rights reserved. © Copyright 2009 Research and Markets0    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster